Evidence map›Paper›PMID 36046762›Full record

ArticleMediators of inflammation2022

Tanshinone IIA Accomplished Protection against Radiation-Induced Cardiomyocyte Injury by Regulating the p38/p53 Pathway.

Gang Wang, Li Ma, Bowen Wang, Fentang Gao, Jianfeng Li, Hongyi Cai, Juan Wang, Tiancheng Zhang, Hao Guo, Ping Xie and 1 more

Abstract read
In one paragraph

Article in Mediators of inflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Chemo-/radiotherapy-induced cardiomyopathy: roles of mitochondria and endoplasmic reticulum.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Review
  4. Article
  5. Article
  6. Integrated Multiomic Analysis Reveals the Therapeutic Potential of Danhong Injection in Mitigating Radiation-Induced Heart Disease by Modulating Ferroptosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gang Wang *The First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou 730000, China.
Li Ma *Gansu Provincial Maternity and Child-Care Hospital, Lanzhou 730000, China.
Bowen WangDepartment of Cardiovascular Medicine, Gansu Provincial Hospital, Lanzhou 730000, China.
Fentang GaoDepartment of Cardiovascular Medicine, Gansu Provincial Hospital, Lanzhou 730000, China.
Jianfeng LiDepartment of Cardiovascular Medicine, Gansu Provincial Hospital, Lanzhou 730000, China.
Hongyi CaiDepartment of Radiotherapy, Gansu Provincial Hospital, Lanzhou 730000, China.
Juan WangDepartment of Cardiovascular Medicine, Gansu Provincial Hospital, Lanzhou 730000, China.
Tiancheng ZhangDepartment of Cardiovascular Medicine, Gansu Provincial Hospital, Lanzhou 730000, China.
Hao GuoSchool of Medicine, Xiamen University, Xiamen 361000, China.
Ping XieDepartment of Cardiovascular Medicine, Gansu Provincial Hospital, Lanzhou 730000, China.ORCID https://orcid.org/0000-0002-9004-9590
Yi LiSchool of Stomatology, Lanzhou University, Lanzhou 730000, China.ORCID https://orcid.org/0000-0001-5380-6567

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Radiotherapy is one of the major strategies for treating tumors, and it inevitably causes damage to relevant tissues and organs during treatment. Radiation-induced heart disease (RIHD) refers to radiation-induced cardiovascular adverse effects caused by thoracic radiotherapy. Currently, there is no uniform standard in the treatment of RIHD. Methods: In our group study, by administering a dose of 4 Gy radiation, we established a radiation injured cardiomyocyte model and explored the regulatory relationship between tanshinone IIA and p38 MAPK in cardiomyocyte injury. We assessed cell damage and proliferation using clonogenic assay and lactate dehydrogenase (LDH) release assay. The measures of antioxidant activity and oxidative stress were conducted using superoxide dismutase (SOD) and reactive oxygen species (ROS). The apoptosis rate and the relative expression of apoptotic proteins were conducted using flow cytometry and western blot. To assess p38 and p53 expressions and phosphorylation levels, western blot was performed. Results: Experimental results suggested that tanshinone IIA restored cell proliferation in radiation-induced cardiomyocyte injury (∗∗ Conclusions: The treatment effects of tanshinone IIA against radiation-induced myocardial injury may be through the regulation of the p38/p53 pathway.

Indexed as

Myocytes, CardiacTumor Suppressor Protein p53AbietanesApoptosisL-Lactate DehydrogenaseReactive Oxygen SpeciesSuperoxide DismutaseAbietanesL-Lactate DehydrogenaseReactive Oxygen SpeciesSuperoxide DismutasetanshinoneTumor Suppressor Protein p53

Identifiers

PMID36046762
PMCPMC9424041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.